Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Stanford University

Neither a doctor nor a teaching hospital

Research payments

$80,524,256

4,381 payments

Through program year 2025, Stanford University is reported as receiving $80,524,256 in research payments, across 4,381 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $7,245,081 432
2024 Research $9,757,441 619
2023 Research $12,649,847 551
2022 Research $13,962,069 621
2021 Research $8,789,050 591
2020 Research $9,870,169 767
2019 Research $18,250,599 800

Breakdown

Who paid Research payments · program years 2019–2025
  1. Ge Healthcare $12,410,629 71 payments
  2. Pfizer Inc. $6,748,313 72 payments
  3. Regeneron Pharmaceuticals, Inc. $3,777,346 391 payments
  4. Merck Sharp & Dohme Corporation $3,626,658 75 payments
  5. Amgen Inc. $3,510,577 31 payments
  6. AbbVie, Inc. $3,470,814 308 payments
  7. Medtronic, Inc. $3,456,857 242 payments
  8. Gilead Sciences, Inc. $3,024,100 114 payments
  9. Abbott Laboratories $2,880,985 303 payments
  10. Sanofi US Services Inc. $2,856,353 7 payments
Studies the money was for Research payments · program years 2019–2025
  1. Selective Trial of Paxlovid for Pasc Stoppasc Randomized Doubleblind Placebocontrolled Pilot Trial of Paxlovid for the Treatment of Pasc $4,124,278 12 payments
  2. Total Therapy Study Xvii (Totxvii) for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphom $3,166,288 3 payments
  3. A Phase II follow-up study to determine whether the addition of whole brain radiotherapy (WBRT) to standard temozolomide chemo-radiotherapy will improve overall survival in patients with newly diagnos $2,811,353 6 payments
  4. Study name not reported $2,448,761 15 payments
  5. MR Research Study $1,687,221 15 payments
  6. Tiger Team Musculoskeletal MRI 2018 $1,647,022 1 payment
  7. HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy $1,628,509 21 payments
  8. Assessment of new head and neck eruption in patients with atopic dermatitis during treatment with Duplimab $1,471,460 21 payments
  9. Spyral Htn-Off Med $1,310,158 34 payments
  10. Mobilizing Antitumor Immunity By Deploying Chemerin to Tumors $1,114,366 9 payments
What the money was spent on Research payments · program years 2019–2025
  1. Patient care $608,399 109 payments
  2. Other $518,733 40 payments
  3. Overhead $334,148 15 payments
  4. Medical research writing or publication $168,755 2 payments
  5. Professional salary support $163,092 1 payment

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record